Braskem S.A.

Análisis de la acción Braskem S.A. (BAK)

$1.660

-0.138 (-8.29%)Al cierre

Loading chart…
Máximo
1.776
Apertura
1.730
Precio medio ponderado por volumen
1.69
Volumen
2.12M
Capitalización
2.68B
Mínimo
1.640
Importe
3.58M
EV/EBITDA, TTM
3.55

Braskem SA is a Brazil-based company primarily engaged in the plastic production. The Company operates in the first and second generations of the petrochemical industry and its activities are divided into three operational segments: Brazil; the United States and Europe; and Mexico. The Brazil segment is focused on the production of polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC) and caustic soda, among others. The United States and Europe segment is responsible for the production, operations, and sales of polypropylene in the United States and Germany. The Mexico segment comprises production, operation, and sale of ethylene, high-density polyethylene (HDPE), and low-density polyethylene (LDPE).

www.braskem.com.br

Análisis de IA of Braskem S.A. (BAK)

Vender

Braskem SA (BAK) is not a good buy right now due to significant financial instability and negative analyst sentiment. The current price is $1.82, and the stock has a forward P/E of 9.78, which indicates potential undervaluation; however, the company has faced serious liquidity issues, as evidenced by its recent emergency protection filing amid debt talks. Furthermore, the stock has a high RSI of 75.63, suggesting it may be overbought. The main risk is the recent downgrade by UBS, which set a price target of $1.50, indicating a potential downside of 17.6% from the current price.

Recomendaciones de analistas (4)

+98.80% de potencial alcista
Comprar
3 Comprar
1 Mantener
0 Vender
Actual: 1.66
Mínimo
3.30
Promedio
3.30
Máximo
3.30

HSBC

2026-09-28

Precio objetivo

—

Mantener

UBS

2026-09-15

Precio objetivo

$4

Vender

JPMorgan

2026-06-30

Precio objetivo

—

Neutral

Citi

2026-06-25

Precio objetivo

—

Vender

BofA

2026-06-05

Precio objetivo

$3

Inferior al mercado

Métricas de valoración

El PER previsto actual de Braskem S.A. (BAK) es 9.78, frente a su media de 5 años de -7.37.

PER previsto

Valor razonable
Media 5A P/E
-7.37
P/E actual
9.78
Sobrevalorada
28.15
Infravalorada
-42.88

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
8.69
EV/EBITDA actual
3.55
Sobrevalorada
14.46
Infravalorada
2.93

Precio/ventas previsto

Infravalorado
Media 5A P/S
0.18
P/S actual
0.01
Sobrevalorada
0.30
Infravalorada
0.07

Ballenas con BAK en cartera

J

Julius Baer Brasil Gestão de Patrimônio e Consultoria de Valores Mobiliários Ltda

+ Con en carteraBAK

+5.46%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-16 (ET)

16:30:00

Stocks Fall as Fed Raises Rates, S&P 500 Drops 0.45%

12:30:00

Stocks Inch Higher as Markets Assess Rate Hike Impact

2026-08-28 (ET)

10:00:00

Braskem SA Trading Resumes

09:30:00

Braskem SA Trading Halted, News Pending

2026-07-28 (ET)

10:30:00

Lallemand and Braskem Launch Bio-Acetone Production Platform

Noticias

Preguntas frecuentes sobre BAK, respondidas por Alphio AI

Braskem SA is a Brazil-based company primarily engaged in the plastic production. The Company operates in the first and second generations of the petrochemical industry and its activities are divided into three operational segments: Brazil; the United States and Europe; and Mexico. The Brazil segment is focused on the production of polyethylene (PE), polypropylene (PP), polyvinylchloride (PVC) and caustic soda, among others. The United States and Europe segment is responsible for the production, operations, and sales of polypropylene in the United States and Germany. The Mexico segment comprises production, operation, and sale of ethylene, high-density polyethylene (HDPE), and low-density polyethylene (LDPE). It operates in the Basic Materials sector.

Braskem SA (BAK) is not a good buy right now due to significant financial instability and negative analyst sentiment. The current price is $1.82, and the stock has a forward P/E of 9.78, which indicates potential undervaluation; however, the company has faced serious liquidity issues, as evidenced by its recent emergency protection filing amid debt talks. Furthermore, the stock has a high RSI of 75.63, suggesting it may be overbought. The main risk is the recent downgrade by UBS, which set a price target of $1.50, indicating a potential downside of 17.6% from the current price.

4 analysts cover BAK: 3 rate it Buy, 1 Hold and 0 Sell. The average price target is 3.30.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar